Moritz Liebert

Moritz Liebert: Email & Phone Number

Opt-Out
Head of Finance Global Pharma Technical Development at Genentech|United States

Position:

Head of Finance Global Pharma Technical Development at Genentech

Location:

United States

LinkedIn
View Moritz Liebert's Email
Up to 10 free lookups. No credit card required.
Last updated: 2026-05-28
Updated: 2026-05-28

Found email addresses for Moritz Liebert:

Business emails:
m************t@roche.com
Personal emails:
m***@roche.com,
m***@hotmail.com,
l***@aol.com

Found phones for Moritz Liebert:

+1-870-***-**61
Searching for Moritz Liebert profiles
0% completed

A different Moritz Liebert?

Sign up to search for other Moritz Liebert's across our 850M+ professionals database

Work Experience 15 years

Head of Finance Global Pharma Technical Development at Genentech

Jan 2026 - Current

Finance Enterprise Partner at Roche

Jan 2024 - Jan 2026

Head of Finance - Drug Substance Manufacturing at Roche

Nov 2020 - Jan 2024

Head of Business Management at Heraeus

Oct 2018 - Nov 2020

Business Unit Controller at Heraeus

Aug 2016 - Oct 2018

Regional Financial Analyst at Heraeus

Feb 2015 - Aug 2016

Trainee Controlling/Finance at Heraeus

Feb 2013 - Jan 2015

Working Student at BearingPoint

Jan 2012 - May 2012

Intern at Porsche Consulting

Jun 2011 - Sep 2011

Moritz Liebert started working in 2011, then the employee has changed 4 companies and 8 jobs. On average, Moritz Liebert works for one company for 1 year 6 months.

Moritz is proficient in Deutsch, Dänisch, and Englisch. Their professional focus is Accounting, Back Office, and Budgets across 3 core areas.

Education

Master's degree at Technische Universität München

Frequently Asked Questions

What is Moritz Liebert's email address?

SignalHire found verified email addresses for Moritz Liebert, both business and personal. Their business email is m************t@heraeus.com, and personal emails include l***@herae.us, m***@roche.com, and m***@hotmail.com.

What is Moritz Liebert's phone number?

SignalHire found multiple verified phone numbers for Moritz Liebert: +1-870-***-**85, and +1-870-***-**61.

How do I contact Moritz Liebert at Genentech?

You can reach Moritz Liebert through SignalHire by unlocking their verified email and direct phone number (free signup, no credit card needed). SignalHire is the fastest route if you need their contact details immediately.

What is Moritz Liebert's professional background?

Moritz Liebert has 15 years of professional experience. They have held roles including Finance Enterprise Partner, Head of Finance - Drug Substance Manufacturing, and Head of Business Management at companies such as Roche, Roche, and Heraeus. Their education includes Master's degree from Technische Universität München.

Is Moritz Liebert's contact information up to date?

Yes. Moritz Liebert's SignalHire profile was last updated on 28 May 2026, reflecting their current position as Head of Finance Global Pharma Technical Development at Genentech in South San Francisco, California, United States.

Other employees at Genentech

Name
Company
Position
Miguel Reyes
Principal Scientist
Get contacts
Florian Ammann
Sr Market Solutions Manager
Get contacts
Scott Gunderman
Business systems Analyst
Get contacts
Christina Whitman
Director - Head Data Management and Architecture
Get contacts
Joan Goodwin
Senior Biomedical Engineer
Get contacts
Sofia Xu
Engineering Manager / Technology Leader
Get contacts
Sasha Sreckovic
Safety Strategy Leader
Get contacts
Alan Adams
Director of Development
Get contacts
Marty Cannistra
Senior Biomedical Engineer
Get contacts
See more profiles

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP